Newsroom

Today's Highlights Include: e-changing kidney swap, climate change is making allergy season even worse, and a Minnesota Milestone: A day without COVID-19 deaths.

Mayo Clinic researchers have developed and validated a new antibody test to diagnose multiple sclerosis (MS). The new test is an automated and cost-effective method compared to other tests used to diagnose MS, according to the research published in Mayo Clinic Proceedings. The test is now available through Mayo Clinic Laboratories.

Today's Highlights Include: A new strategy for staying one step ahead of the virus, Pfizer CEO says another Covid booster will be needed, and Senate votes to make daylight saving time permanent.

Today's Highlights Include: MN has 14 hospitals in Newsweek's U.S. Top 500; Mayo best in the world, medical supplies head to Ukraine from Rochester, and how does your body react to stress?

Today's Highlights Include: Biden wants to move U.S. past Covid. Here’s his plan to do it, hospitals plan to continue mask wearing, regardless of updated CDC guidance, and new data shows COVID-19 vaccinations during pregnancy benefits newborns.

Today's Highlights Include: Mayo experts encourage booster doses, caution against dropping masks, Black history month: Health & Wellness, and 13 processed foods that are actually healthy.

Of five articles listed among the Journal of Clinical Microbiology’s “Top Cited” collection from the last two years, three included Mayo Clinic authors with papers focused on SARS-CoV-2.

This week on the podcast, Elitza Theel, Ph.D., director of Mayo Clinic’s Infectious Diseases Serology Laboratory, joins "Answers From the Lab" with Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Theel discuss antibody testing for COVID-19, including why this testing is done and when it’s most useful.

The NIH has awarded $40 million to Mayo Clinic to develop a comprehensive biorepository as the source of clinical samples for long COVID research studies.

Representing Mayo Clinic at the event, Dr. William Morice contributed his expertise and experience as leaders from around the world redoubled their commitment to end the COVID-19 pandemic.

In the wake of the CDC withdrawing its emergency use authorization request for a coronavirus PCR test, social media posts claimed the action signaled that the tests were flawed. Dr. Matthew Binnicker explains why those claims are false.

Mayo Clinic Laboratories reaches patients around the globe. Alumni magazine highlights this work as it details the labs' international strategy.

Matthew Binnicker, Ph.D., director of the Clinical Virology Laboratory in Mayo Clinic’s Division of Clinical Microbiology, considers the prospects for COVID-19 this fall as the traditional influenza season ramps up.